Best of the Web

CellDeath.de

Whether you pronounce it “AY-POP-TOE-SIS” or “AP-O-TOE-SIS,” scientists with a morbid interest in cell death will enjoy CellDeath.de, an initiative started and maintained by Ph.D. students. The site is clearly a work-in-progress, as evidenced by some blank pages and outdated conference dates/publications. However, the scaffolding is in place to make this site a hub for apoptosis research. Currently, there is an expansive encyclopedia (or rather, an “apoptopedia”) of apoptosis-related terms, as well as a collection of protocols. The links page features not only apoptosis-related sites, but also scientific glossaries and a very useful list of scientific databases. Additionally, there is an incomplete list of labs studying apoptosis, to which any cell death researcher can add him/herself. This site has great potential, but it is dependent on users contributing information—so get the word out!

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

GEN Poll

Secure Science

Should bans on science education, of the sort imposed on Iranians hoping to study physics and engineering in the United States, encompass other nationals and other fields of study, including biotechnology?

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

56.6%

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.